Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Contraceptives in HIV Women on LPV/r
NCT00125983Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of ethinyl estradiol + norelgestromin in pregnancy (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Ortho Evra transdermal contraceptive ethinyl estradiol (EE) area under the concentration-time curve (AUC) at Day 24. Status: completed.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00125983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125983.